Full Text
Budget Impact Analysis of Dapagliflozin for the Treatment of Type 2 Diabetes Mellitus in China

Abstract

Authors

C Liu S Xie J Wu

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×